Buch, Englisch, 852 Seiten, Format (B × H): 177 mm x 260 mm, Gewicht: 1744 g
Reihe: Medical Psychiatry Series
A Biological Approach, Second Edition
Buch, Englisch, 852 Seiten, Format (B × H): 177 mm x 260 mm, Gewicht: 1744 g
Reihe: Medical Psychiatry Series
ISBN: 978-0-8247-0872-6
Verlag: Taylor & Francis Inc
Zielgruppe
Professional and Professional Practice & Development
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
A conceptual history of anxiety and depression, Gerrit Glas; epidemiology of depression and anxiety, Borwin Bandelow; comorbidity of depression and anxiety, Giovanni B. Cassano, Nicolo B. Rossi, Stefano Pini; anxiety, depression, and personality, Harald N. Aschauer and Monika Schlogelh; is there a common aetiology for depression and anxiety?, Dean F. MacKinnon and Rudolf Hoehn-Saric; measurements of depression and anxiety disorders, Saena Arbabzadeh-Bouchez and Jean Pierre Lepine; combining psychotherapy and pharmacotherapy for depression and anxiety, Robert H. Howland and Michael E. Thase; genetics of depression, Wolfgang Maier and Kathleen Merikangas; genetics of anxiety, Wolfgang Maier; stress-responsive neuro-hormones in depression and anxiety, Andreas Strohle and Florian Holsboer; neuropeptide alterations in depression and anxiety disorders, David A. Gutman, Dominique L. Musselman, and Charles B. Nemeroff; immunology in anxiety and depression, Norbert Muller and Markus J. Schwarz; brain imaging in depression and anxiety, Peter S. Talbot, Sanjay J. Mathew, and Marc Laruelle; neurobiology of anxiety and depression, Philip T. Ninan and Thomas K. Cummins; intracellular signalling transduction dysregulation in depression and possible future targets for antidepressant therapy - beyond the serotonin hypothesis, Andrea Trentani, S. Kuipers, G.J. Ter Horst, and Johan A. den Boer; norepinephrine in depression and anxiety, Pedro L. Delgado; benzodiazepines, benzodiazepine receptors, and endogenous ligands, Werner Sieghart; antidepressants for the treatment of depression and anxiety disorders - same mechanism of action?, R. Hamish McAllister-Williams and Stephen P. Tyrer; studies on the neurobiology of depression,. Carlos A. Zarate and Dennis S. Charney; animal models of subtypes of depression, Paul Willner and Paul J. Mitchell; pathogenesis of depression - reconsideration of neurotransmitter data by depletion paradigms, Alexander Neumeister and Asastasios Konstantinidis; effects of antidepressants on specific neurotransmitters - are such effects relevant to therapeutic actions?, Brian Leonard; pharmacotherapy of depression - the acute and long-term perspective, Robert J. Boland and Martin B. Keller; pharmacotherapy of bipolar disorder, Kenneth Thau and Anna Maria Steeruwitz; development of new treatment options for depression, Siegfried Kasper and Alan F. Schatzberg; the depressed patient - from nonresponse to complete remission, Koen Demyttenaere and Jurgen DeFruyt. (Part contents).